Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2982 | Placebo pMDI Wiki | 1.00 |
| drug3627 | Simultaneous EGD and colonoscopy Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This pilot study is being performed to assess the efficacy and safety of inhaled ensifentrine delivered via pMDI compared with a matching placebo in conjunction with standard of care treatments on recovery in patients hospitalized due to COVID-19 infection.
Description: Recovery = first day on which subject satisfies one of the following categories: not hospitalized, no limitations of activities; or not hospitalized, limitation of activities, home oxygen requirement, or both.
Measure: Proportion of patients with recovery Time: Day 29Description: Recovery = first day on which subject satisfies one of the following categories: not hospitalized, no limitations of activities; or not hospitalized, limitation of activities, home oxygen requirement, or both.
Measure: Time to recovery Time: Day 1 to Day 29Description: All-cause mortality
Measure: Mortality rate Time: Days 29 and 60Description: respiratory failure = requiring invasive mechanical ventilation or extracorporeal membrane oxygenation [ECMO]
Measure: Proportion of patients alive and not in respiratory failure Time: Day 29Description: breaths/minute
Measure: Respiration Rate Time: Day 1 to Day 29Description: beats/minute
Measure: Heart Rate Time: Day 1 to Day 29Description: mmHg
Measure: Blood Pressure Time: Day 1 to Day 29Description: AVPU scale
Measure: Level of Consciousness Time: Day 1 to Day 29Description: SpO2 %
Measure: Oxygen saturation Time: Day 1 to Day 29Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports